Can-Fite BioPharma Begins Safety Study of Piclidenoson in Dogs
Can-Fite BioPharma Begins Safety Study of Piclidenoson in Dogs
By Chris Wack Can-Fite BioPharma Ltd. said its veterinary development and commercialization partner Vetbiolix, a France-based veterinary biotech company,
News story posted on 2021-11-23T12:44:00.0000000Z